news
NHS England to fund HIV treatment Rezolsta (darunavir/cobicistat)
30 March 2016 | By Victoria White
Darunavir/cobicistat is indicated for use in combination with other antiretroviral medications, for treating adults with HIV-1...
List view / Grid view
NHS
news
MenB vaccine Bexsero might see private uptake in the UK
9 March 2016 | By GlobalData
The UK Department of Health’s rejection of a petition to expand the routine administration of MenB vaccine Bexsero may lead to parents and physicians to consider purchasing the vaccine themselves...
news
Eisai criticises NHSE for further delaying access to cancer treatments
26 February 2016 | By Victoria White
New licensed drugs that have been denied access since May 2015 will have to wait until at least July 2016 before they can be considered for the new Cancer Drug Fund...
news
Public Accounts Committee publishes report on the Cancer Drugs Fund
5 February 2016 | By Victoria White
A Public Accounts Committee has released its recommendations for the reform of the Cancer Drugs Fund...
news
Pharmaceutical industry to pay £550 million in 2016 as part of the PPRS
22 December 2015 | By Victoria White
The PPRS is a unique scheme where pharmaceutical companies agreed to contribute towards the cost of medicines, with the aim of making the latest treatments affordable for the NHS...
news
Cancer Drugs Fund public consultation launched
19 November 2015 | By Victoria White
The new Cancer Drugs Fund will become an instrument for the collection of important information on longer term benefits which may not be available at the time of licensing...
news
SMC accepts six new medicines for use by NHS Scotland
12 October 2015 | By Victoria White
The medicines accepted by the SMC include Herceptin for stomach cancer, radium 223 (Xofigo) and abiraterone (Zytiga) for prostate cancer, and nintedanib (Ofev) for idiopathic pulmonary fibrosis
news
23 drugs to be axed from the Cancer Drug Fund
7 September 2015 | By Victoria White
The announcement follows a review that found that CDF spending would rise to around £410 million for this year - an over-spend of £70m from the budget set in April 2015...
news
Regorafenib now available on NHS Wales for treatment of advanced GIST
24 July 2015 | By Victoria White
Regorafenib has been recommended for use on NHS Wales as a third-line treatment for patients with advanced gastrointestinal stromal tumours (GIST).
news
NICE recommends Tegaderm CHG dressing to reduce catheter infections
22 July 2015 | By Victoria White
NICE has recommended the use of 3M Tegaderm CHG IV securement dressing to hold catheters in place securely, reducing the risk of catheter related infections...
news
UK government intends to publish cost of NHS drugs to shame patients
2 July 2015 | By Victoria White
Jeremy Hunt has called for a new social contract between the public, health and care services, and has urged the public to take more personal responsibility...
news
NICE publishes updated guidance to help GPs and patients recognise the signs of cancer
23 June 2015 | By Victoria White
NICE has updated and redesigned its guideline to support GPs and other primary care professionals to recognise the signs and symptoms of cancer...
news
Healthcare firms need to move away from a one-size-fits-all mindset when it comes to supply chains, says Crimson & Co
11 June 2015 | By Victoria White
Healthcare firms have to be prepared to break with tradition and move away from employing a one-size-fits-all approach with existing suppliers...
news
SMC accepts seven new medicines for use in NHS Scotland
11 May 2015 | By Victoria White
SMC has accepted seven new medicines for use in NHS Scotland. Two of these medicines, Azerra and Zydelig, were considered under SMC’s PACE process...
news
Handheld device identifies pressure ulcers early and saves hospitals £50,000 per month
6 May 2015 | By Victoria White
A handheld device that identifies pressure ulcers in the earliest stage of their development has saved two UK NHS hospitals £50,000 per month during trials...
